CCT roaring, textiles stumble; 175% revenue surge masks margin hedging

Textile revenue ₹132 Cr vs ₹137 Cr YoY (down 3.6%); monsoon/tariff headwinds acknowledged

Blended EBITDA margin 15.7%; management deflected on standalone CCT margin (indicated 13-14%)

Operating at 63% utilization (93.2K MTPA used); ample headroom suggests demand not yet explosive

Q1 run rate ~USD 30M annualized (₹245 Cr/0.25 ÷ 65 allocation); 6.7x growth required; management hedged on price independence when pressed

Management walked back hard target, emphasizing flexibility over fixed margins; no specific path outlined

Q1 FY27 ₹132 Cr vs ₹137 Cr Q1 FY26 (−3.6%); management blamed monsoon, tariffs, competition; contradicts prior 'encouraging demand' guidance

Previously guided 18–20% blended margin (from prior call). Q1 at 15.7%; management now emphasizes flexibility over fixed targets, retreated from hard 18% guidance

Texas plant 80K→148K MTPA (+69K MTPA). At 63% utilization Q1, headroom for 30–40% revenue growth without additional capex (management comment)

Aramco $8B order win with Fineotex specialty package (5–6 product lines); management claims competing with USA top specialty players on pricing + performance equivalence

Cross-selling, technology transfer, green chemistry, supplier negotiation leverage mentioned; margins improved to blended 15.7% from 13.93% LQ (150 bps)

Currently at 63% of Texas ops; can add 30-40% on current business. Q1 is base quarter for capacity and revenue. 100+ product categories mean volume/pricing mix varies by well quality and crude type.

Guidance based on order book, not crude. Crude at USD 90-100 now; higher prices = higher US activity. But extraction already invested 2+ years ahead; low-cost production (USD 10 ME, USD 30 US) means USD 60+ crude won't stop activity.

Deflected to blended 15.7% (up 150 bps LQ). CCT contributes 65% revenue; margins must be 'much better than before' due to synergies and green chemistry demand.

No fixed blended margins ever. Cannot say no to customer; must balance volumes vs margins. Flexibility more important than hard targets. Long-term strategy is leadership, not fixed EBITDA %.

No traditional 'order book' concept; wells come in bunches. Synergies: tech transfer, cost reduction, green products, supplier pricing leverage from capital infusion. Perennial revenue once well production starts.

History shows we doubled CCT in recent quarters despite industry 5-7%. Sustainability tailwind, me-too snowball effect from customer replication, best-in-class supplier relationships, right timing. Two years to FY28—should not be challenge.

Minor 1-2% variance, not a dip. Monsoon seasonal; expensive performance chemicals softer. Competition in Indian textile. Expecting improvement; increased Bangladesh team, trade fair participation.

US model is service-oriented; customers pay premium for last-mile delivery control. Insurance, liability managed in separate entity. Competitive advantage + margin accretion. Not comparable to Indian model.

Margins sustainable. War surcharge system in US lets us pass cost to customers; suppliers also levy surcharges. We're not traders holding inventory; we're specialty chemical provider with cost-pass-through built in.

Recently started Canada sales; Guyana/Suriname production set-up in discussion. Saudi order recently won after 2-year R&D; customer got USD 8B Aramco order requiring our specialty package (5-6 product lines). Competing with US top players on price + performance.

Q1 annualized run rate ~USD 30M (₹245 Cr/0.25 ÷ 65%). Guidance based on order book + sustainability tailwind. No commodity upside; mgmt emphasizes customer demand + large contracts.

Textile at -3.6% YoY; recovery expected H2 via Bangladesh, trade fairs. CCT needs 2-3x growth to hit ₹1,520 Cr annualized for USD 200M FY28.

CCT capacity expansion, geographic expansion (Canada, Guyana, Saudi) underway. Large customer concentration (Shell, Exxon) provides stability.

Management walked back hard 18% target in Q&A. Now emphasizes flexibility over fixed margins. CCT standalone ~13-14%; India textile higher. Suggests caution on expansion path.

Q1 gross margin 35.42%. Management confident in surcharge mechanism (USA), cost-plus model ensures margin protection.

Sustainability tailwind, ESG badge (Dun & Bradstreet), green products commanding higher margins. Real but not quantified.

Management stated only USD 1-2M additional capex needed for shift expansion at Texas. Existing equipment can double output via two-shift ops.

CrudeChem second major acquisition (first 2011 Malaysia). Management 'always looking' but emphasizes synergy + value discipline. No timeline for next deal.

Textile revenue down 3.6% YoY (₹132 vs ₹137 Cr). Geopolitical, tariffs, Indian competition blamed. No specific recovery plan beyond 'Bangladesh expansion' and 'trade fairs'.

CrudeChem at 65% of consolidated revenue (~₹245 Cr Q1). Oil & gas orders lumpy ('wells come in bunches'). Weather (storms, snowfall) can halt operations 1-2 weeks. USD 200M FY28 guidance contingent on order acceleration; current run rate only USD 30M annualized.

Management hedged on 18% EBITDA target (from prior guidance 18-20%). Currently 15.7% blended. CCT standalone likely 13-14%; India textile higher. Scaling to 18% requires CCT volume ramp + India margin hold, both uncertain.

CrudeChem acquisition closed Dec 2025 (Q4 FY26). Q1 FY27 first full quarter. Management claims synergies (cost reduction, tech transfer, green products) but standalone margin not disclosed. Scale-up from 63% to 80%+ utilization dependent on flawless execution.

Management claimed CCT guidance independent of crude prices, later walked back to 'higher oil = higher US activity.' USD 60/bbl floor may protect, but energy capex cycles (2008-09, 2015-16) have historically halted drilling. Multi-year well investment lag mitigates, but not elimination.